Glycemic variability: is it important in T2D? | With Dr Irl Hirsch
HbA1c is the traditional primary metric for glycemia, but as a measure of average glycemia over 3 months, how much does it really tell us about glycem...
Diabetes Knowledge in Practice Podcast
Share:
Listens: 327
About
A biweekly summary of new trial data, guideline recommendations and expert opinion across diabetes care, run by Diabetes Knowledge in Practice (www.knowledgeinpractice.eu). This podcast is intended for healthcare professionals only. Featuring interviews with leading experts from across the globe. This independent educational activity is supported by an educational grant from Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Novo Nordisk A/S has had no influence on the content of this education.
Introducing injectable therapies | With Dr Ronald Goldenberg
Clinical inertia in type 2 diabetes is particularly pronounced for injectable agents, with delays of 6-8 years reported to move from oral agents to in...
EASD 2021 | With Prof. Stephen Bain
This week we have more congress highlights from the 2021 annual meeting of the European Association for the Study of Diabetes (EASD), held online from...
Newsflash | Glaucoma risk with GLP-1 RAs
Hear a 5-minute summary of a retrospective study investigating whether GLP-1 receptor agonists might affect the development of glaucoma in people with...
Newsflash | Cardiac function with short-term GLP-1 RA treatment
Hear a 5-minute summary of a small study investigating whether the GLP-1 receptor agonist liraglutide affected diastolic function in people with type ...
Identifying NASH in T2D | With Prof Arun Sanyal
People with type 2 diabetes are at high risk of developing NASH, increasing their risk of poor outcomes. However, the only way to confirm a diagnosis ...
NASH risk reduction in people with T2D and NAFLD | With Dr Stephen Harrison
Following last week’s discussion of the prevalence of NAFLD in people with type 2 diabetes, this week we’re joined by Dr Stephen Harrison to discuss w...
NAFLD: what your patients need to know | With Prof. William Alazawi
Non-alcoholic fatty liver disease (NAFLD) a condition where disruptions and dysregulation of lipids in the body causes an excessive build-up of fat in...
Newsflash | VERTIS CV analysis: Ertugliflozin outcomes by baseline metformin use
In another news episode, hear a 5-minute summary of the VERTIS CV post hoc analysis presented at ESC 2021. VERTIS CV was the the cardiovascular outcom...
ESC 2021 | With Prof. Subodh Verma & Prof. Darren McGuire
Join us this week for another congress highlights episode covering the recent European Society of Cardiology congress, held virtually from 27-30 Augus...